These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
777 related articles for article (PubMed ID: 15226229)
1. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229 [TBL] [Abstract][Full Text] [Related]
2. [Cardiac disease in patients with tumors and tumor therapy]. Hoppe UC Med Klin (Munich); 2006 Mar; 101 Suppl 1():31-5. PubMed ID: 16802515 [TBL] [Abstract][Full Text] [Related]
3. Anthracycline cardiotoxicity in childhood. Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471 [TBL] [Abstract][Full Text] [Related]
4. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435 [TBL] [Abstract][Full Text] [Related]
5. Predicting and preventing the cardiotoxicity of cancer therapy. Anderson B; Sawyer DB Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852 [TBL] [Abstract][Full Text] [Related]
6. Pathology of radiation and anthracycline cardiotoxicity. Berry GJ; Jorden M Pediatr Blood Cancer; 2005 Jun; 44(7):630-7. PubMed ID: 15825155 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. Yeh ET; Bickford CL J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246 [TBL] [Abstract][Full Text] [Related]
8. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Raschi E; Vasina V; Ursino MG; Boriani G; Martoni A; De Ponti F Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849 [TBL] [Abstract][Full Text] [Related]
9. Prevention and management of cardiotoxicity from antineoplastic therapy. Chanan-Khan A; Srinivasan S; Czuczman MS J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825 [TBL] [Abstract][Full Text] [Related]
10. [Cardiac toxicity in cancer therapy]. Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515 [TBL] [Abstract][Full Text] [Related]
11. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz SE Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284 [TBL] [Abstract][Full Text] [Related]
12. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Jones RL; Ewer MS Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459 [TBL] [Abstract][Full Text] [Related]
13. [Cardiac disease in patients with tumors and tumor therapy]. Hoppe UC Internist (Berl); 2007 Mar; 48(3):268-75. PubMed ID: 17287966 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of cardiotoxicity induced by anthracyclines. Elliott P Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283 [TBL] [Abstract][Full Text] [Related]